Completed OBSERVATIONAL NCT00578851

A Clinical Investigation of the C2a-Taper™ Acetabular System

Post Approval Study of the C2a-Taper™ Acetabular System

Sponsor: Biomet Orthopedics, LLC

Conditions Avascular Necrosis Congenital Hip Dysplasia Osteoarthritis Traumatic Arthritis

Interventions C2a - Taper™ Acetabular System

Updated 7 times since 2017 Last updated: Jun 19, 2017 Started: Apr 30, 2006 Primary completion: Oct 31, 2014 Completion: Oct 31, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Avascular Necrosis and Congenital Hip Dysplasia, this trial is completed. The trial is conducted by Biomet Orthopedics, LLC and has accumulated 7 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Jan 2021 — Jul 2024 [monthly]

Completed
Jun 2018 — Jan 2021 [monthly]

Completed
Apr 2018 — Jun 2018 [monthly]

Completed

Phase: NA → None

▶ Show 2 earlier versions

Feb 2017 — Apr 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Apr 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Biomet Orthopedics, LLC

Data source: Zimmer Biomet

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Cedar Rapids, United States
• Lexington, United States